M42 is a global health champion powered by artificial intelligence, technology and genomics to advance innovation in health for people and the planet. Headquartered in Abu Dhabi, M42 combines its specialized, state-of-the-art facilities with integrated health solutions like genomics and biobanks, and harnesses advanced technologies to deliver precise, preventive and predictive care, to impactfully disrupt traditional healthcare models and positively impact lives globally.
Established in 2022, following the merger of G42 Healthcare and Mubadala Health, M42 operates more than 480 facilities in 26 countries and over 20,000 employees. M42 includes renowned healthcare providers including Cleveland Clinic Abu Dhabi, Danat Al Emarat, Diaverum, Imperial College London Diabetes Centre, Sheikh Sultan bin Zayed Hospital, and Moorfields Eye Hospital Abu Dhabi. As well as operating the Emirati Genome Programme, M42 runs the Abu Dhabi BioBank and Abu Dhabi Health Data Services, a global tech-enabled healthcare company operating Malaffi.
About the Opportunity
M42 is planning significant external growth in the next 2-3 years, which is likely to include acquisitions in the region and globally, across multiple healthcare sectors (services / provision, digital health, OMICS, Life Sciences). To support the execution of our strategic plan, we are seeking a Senior Associate, Investments to join our investments team.
As a Senior Associate, in the investments team, you will play a critical role in the evaluation of M&A and investment opportunities and other strategic projects to ensure M42 achieves its strategic objectives.
Role will be focused on external growth opportunities; it is likely to also include organic growth projects or special situations. This is a unique opportunity for an investment professional with a strong corporate finance background to make a tangible impact within a fast-paced, high-growth environment.
#LI-DNI
Software Powered by iCIMS
www.icims.com